Xilio Therapeutics, Inc. — SC 13G/A Filings
14 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Xilio Therapeutics, Inc. (XLO), sorted by most recent first. Each row links to the full filing on EdgarLookup. Xilio Therapeutics, Inc. has filed 14 SC 13G/A documents with the SEC since 2021. To view all SEC filings by Xilio Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SC 13G/A | 0001193125-24-258836 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119012 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-004587 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000315066-24-002932 | Nov 12, 2024 | — |
| SC 13G/A | — | 0001172661-24-001733 | Apr 5, 2024 | — |
| SC 13G/A | AMENDMENT NO. 2 | 0001214659-24-002001 | Feb 6, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-001919 | Feb 5, 2024 | — |
| SC 13G/A | — | 0000315066-23-001351 | Feb 9, 2023 | — |
| SC 13G/A | — | 0001193805-22-001801 | Dec 29, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-118672 | Nov 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-022767 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A NO.1 | 0001193125-22-039224 | Feb 14, 2022 | — |
| SC 13G/A | — | 0001193805-22-000252 | Feb 11, 2022 | — |
| SC 13G/A | — | 0000315066-22-001246 | Feb 9, 2022 | — |